Your browser doesn't support javascript.
loading
Drug-disease interactions in Swedish senior primary care patients were dominated by non-steroid anti-inflammatory drugs and hypertension - a population-based registry study.
Schmidt-Mende, Katharina; Andersen, Morten; Wettermark, Björn; Hasselström, Jan.
Afiliação
  • Schmidt-Mende K; Academic Primary Health Care Centre, Region Stockholm and Division of Family Medicine, Department of Neurobiology, Care Sciences and Society, Karolinska Institute, Sweden.
  • Andersen M; Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Wettermark B; Department of Pharmacy, Disciplinary Domain of Medicine and Pharmacy, Uppsala University, Uppsala, Sweden.
  • Hasselström J; Academic Primary Health Care Centre, Region Stockholm and Division of Family Medicine, Department of Neurobiology, Care Sciences and Society, Karolinska Institute, Sweden.
Scand J Prim Health Care ; 38(3): 330-339, 2020 Sep.
Article em En | MEDLINE | ID: mdl-32723202
ABSTRACT

OBJECTIVE:

Drug-disease interactions (DDSIs) are present when a drug prescribed for one disease worsens a concomitant disease. The prevalence of DDSIs in older patients in primary care is largely unknown, as well as to what extent physicians individualize drug prescribing in relation to concomitant diseases. We therefore analysed the prevalence of DDSIs in older patients in primary care and explored to what extent physicians take possible DDSIs into account when prescribing. Design and

Setting:

Cross-sectional population-based register study in primary care in Region Stockholm, Sweden. Thirty-one DDSIs derived from Irish STOPP-START-Criteria were assessed. We derived data from a regional administrative healthcare database including information on all healthcare consultations and dispensed prescription drugs in the region. Data on demography, diagnoses, drug dispensations and healthcare consumption were extracted. Drugs were assessed during 2016.

SUBJECTS:

A total of 336,295 patients aged ≥65 registered with one of the 206 primary care practices in Region Stockholm. MAIN OUTCOME

MEASURES:

Prevalence and prevalence differences for DDSIs.

RESULTS:

In 10.8% of older patients, at least one DDSI was observed. Non-steroidal anti-inflammatory drugs (NSAIDs) were implicated in more than 75% of cases. The most common DDSI was NSAID/hypertension (8.1%), followed by NSAID/cardiovascular disease and loop diuretics/urinary incontinence (both 0.7%). The use of NSAIDs among patients with heart failure or impaired renal function was 15% lower than among patients without these diseases.

CONCLUSION:

DDSIs were present in every tenth older patient in primary care. Patients with cardiovascular disease receive NSAIDs to a lower extent, possibly indicating physician awareness of DDSI. Key points Evidence on the prevalence of drug-disease interactions in older patients in primary care is sparse despite their potential to cause harm. In this study, we found that every 10th older patient attending primary care had at least one drug-disease interaction. Interactions with NSAIDs were far more common than interactions with other drugs. The use of NSAIDs among patients with heart failure or impaired renal function was 15% lower than among patients without these diseases.
Assuntos
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Medicamentos sob Prescrição / Hipertensão Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Aged / Humans País/Região como assunto: Europa Idioma: En Revista: Scand J Prim Health Care Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Suécia

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Medicamentos sob Prescrição / Hipertensão Tipo de estudo: Observational_studies / Prevalence_studies / Risk_factors_studies Limite: Aged / Humans País/Região como assunto: Europa Idioma: En Revista: Scand J Prim Health Care Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Suécia